Literature DB >> 31386559

Multiparametric and multiregional diffusion features help predict molecule information, grade and survival in lower-grade gliomas: a feasibility study.

Hai Lin1,2,3, Yanwen Xu2,3, Lei Chen3,4, Peng Na2,3, Weiping Li1,3,4.   

Abstract

OBJECTIVE: This study was to investigate the relationship of diffusion features with molecule information, and then predict grade and survival in lower-grade gliomas.
METHODS: 65 patients with primary lower-grade gliomas (WHO Grade II & III) who underwent conventional MRI and diffusion tensor imaging were retrospectively studied. The tumor region was automatically segmented into contrast-enhancing tumor, non-enhancing tumor, edematous and necrotic volumes. Diffusion features, including fractional anisotropy (FA), axial diffusivity, radial diffusivity and apparent diffusion coefficient (ADC), were extracted from each volume using histogram analysis. To estimate molecule biomarkers and predict clinical characteristics of grade and survival, support vector machine, generalized linear model, logistic regression and Cox regression were performed on the related features.
RESULTS: The diffusion features in non-enhancing tumor volume showed differences between isocitrate dehydrogenase mutant and wild-type gliomas. And the mean accuracy of support vector machine classifiers was 0.79. Ki-67 labeling index was correlated with these features, which were combined to significantly estimate Ki-67 expression level (r = 0.657, p < 0.001). These features also showed differences between Grade II and III gliomas. A combination of them for grade classification resulted in an area under the curve of 0.914 (0.857-0.971). Mean FA and fifth percentile of ADC were independently associated with overall survival, with lower FA and higher ADC showing better survival outcome.
CONCLUSION: In lower-grade gliomas, multiparametric and multiregional diffusion features could help predict molecule information, histological grade and survival. ADVANCES IN KNOWLEDGE: The multi parametric diffusion features in non-enhancing tumor were associated with molecule information, grade and survival in lower-grade gliomas.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31386559      PMCID: PMC6849676          DOI: 10.1259/bjr.20190324

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  33 in total

1.  Brain dysmyelination and recovery assessment by noninvasive in vivo diffusion tensor magnetic resonance imaging.

Authors:  Laura A Harsan; Patrick Poulet; Blandine Guignard; Jérôme Steibel; Nathalie Parizel; Paulo Loureiro de Sousa; Nelly Boehm; Daniel Grucker; M Said Ghandour
Journal:  J Neurosci Res       Date:  2006-02-15       Impact factor: 4.164

2.  Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features.

Authors:  Philipp Kickingereder; David Bonekamp; Martha Nowosielski; Annekathrin Kratz; Martin Sill; Sina Burth; Antje Wick; Oliver Eidel; Heinz-Peter Schlemmer; Alexander Radbruch; Jürgen Debus; Christel Herold-Mende; Andreas Unterberg; David Jones; Stefan Pfister; Wolfgang Wick; Andreas von Deimling; Martin Bendszus; David Capper
Journal:  Radiology       Date:  2016-09-16       Impact factor: 11.105

3.  A prognostic model based on preoperative MRI predicts overall survival in patients with diffuse gliomas.

Authors:  A Hilario; J M Sepulveda; A Perez-Nuñez; E Salvador; J M Millan; A Hernandez-Lain; V Rodriguez-Gonzalez; A Lagares; A Ramos
Journal:  AJNR Am J Neuroradiol       Date:  2014-01-23       Impact factor: 3.825

4.  IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO.

Authors:  David E Reuss; Yasin Mamatjan; Daniel Schrimpf; David Capper; Volker Hovestadt; Annekathrin Kratz; Felix Sahm; Christian Koelsche; Andrey Korshunov; Adriana Olar; Christian Hartmann; Jaap C Reijneveld; Pieter Wesseling; Andreas Unterberg; Michael Platten; Wolfgang Wick; Christel Herold-Mende; Kenneth Aldape; Andreas von Deimling
Journal:  Acta Neuropathol       Date:  2015-05-12       Impact factor: 17.088

5.  Genetically Defined Oligodendroglioma Is Characterized by Indistinct Tumor Borders at MRI.

Authors:  D R Johnson; F E Diehn; C Giannini; R B Jenkins; S M Jenkins; I F Parney; T J Kaufmann
Journal:  AJNR Am J Neuroradiol       Date:  2017-01-26       Impact factor: 3.825

6.  Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.

Authors:  Jordi Bruna; Marta Brell; Isidre Ferrer; Pepita Gimenez-Bonafe; Avelina Tortosa
Journal:  Neuropathology       Date:  2007-04       Impact factor: 1.906

7.  Potential role of preoperative conventional MRI including diffusion measurements in assessing epidermal growth factor receptor gene amplification status in patients with glioblastoma.

Authors:  R J Young; A Gupta; A D Shah; J J Graber; A D Schweitzer; A Prager; W Shi; Z Zhang; J Huse; A M P Omuro
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-27       Impact factor: 3.825

8.  The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma.

Authors:  Xiang Liu; Rajiv Mangla; Wei Tian; Xing Qiu; Dongmei Li; Kevin A Walter; Sven Ekholm; Mahlon D Johnson
Journal:  J Neurooncol       Date:  2017-09-09       Impact factor: 4.130

9.  Integrative Diffusion-Weighted Imaging and Radiogenomic Network Analysis of Glioblastoma multiforme.

Authors:  Dieter Henrik Heiland; Carl Philipp Simon-Gabriel; Theo Demerath; Gerrit Haaker; Dietmar Pfeifer; Elias Kellner; Valerij G Kiselev; Ori Staszewski; Horst Urbach; Astrid Weyerbrock; Irina Mader
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

10.  International Society Of Neuropathology--Haarlem consensus guidelines for nervous system tumor classification and grading.

Authors:  David N Louis; Arie Perry; Peter Burger; David W Ellison; Guido Reifenberger; Andreas von Deimling; Kenneth Aldape; Daniel Brat; V Peter Collins; Charles Eberhart; Dominique Figarella-Branger; Gregory N Fuller; Felice Giangaspero; Caterina Giannini; Cynthia Hawkins; Paul Kleihues; Andrey Korshunov; Johan M Kros; M Beatriz Lopes; Ho-Keung Ng; Hiroko Ohgaki; Werner Paulus; Torsten Pietsch; Marc Rosenblum; Elisabeth Rushing; Figen Soylemezoglu; Otmar Wiestler; Pieter Wesseling
Journal:  Brain Pathol       Date:  2014-09-10       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.